Novavax | NVAX - Себестоимость





Себестоимость Изменить Дата
Adma Biologics USD 33.74M 16.65M 2026-03
Agenus USD 642K 399K 2025-09
AstraZeneca USD 2.52B 2.73B 2026-06
BioCryst Pharmaceuticals USD 3.84M 5.68M 2026-06
Cassava Sciences USD 3.96M 1.16M 2025-09
Geron USD 1.69M 386K 2026-03
GlaxoSmithKline GBP 2.07B 192M 2026-06
MannKind USD 34.21M 5.38M 2026-06
Merck USD 3.14B 200M 2026-06
Minerva Neurosciences 386K 31K 2024-06
Moderna USD 93M 862M 2026-06
Novartis USD 3.46B 83M 2026-03
Novavax USD 22.1M 608K 2025-12
Pfizer USD 4.09B 498M 2026-06
Sanofi EUR 3.02B 656M 2026-06
Sarepta Therapeutics USD 150.1M 40.64M 2026-06
TG Therapeutics USD 41.19M 7.68M 2026-06